Nasdaq
ATHE
Alterity Therapeutics Limited
- Health Care
- Australia
- 1 day
- +4.3%
- 1 month
- −16.9%
- 1 year
- −11.5%
$4.56 · Mkt cap $82.7M
At the 6 Aug 2026 close
A foreign company trading in the US through depositary receipts.
Nasdaq
Alterity Therapeutics Limited
$4.56 · Mkt cap $82.7M
At the 6 Aug 2026 close
A foreign company trading in the US through depositary receipts.
Alterity Therapeutics Limited trades under the ticker ATHE on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). Its market capitalisation is $82.7M. The last closing price was $4.56, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is −11.5%, and −16.9% over the past month. Returns are price returns and exclude dividends.
This page exists because ATHE is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.